摘要
【摘要】 目的：对比分析瑞舒伐他汀与阿托伐他汀治疗老年不稳定性心绞痛的效果。方法：此次研究的对象是选择笔者所在医院 2018年 6月 -2019年 6月收治的老年不稳定性心绞痛患者 124例，将其临床资料进行回顾性分析，并随机分为 A组和 B组，每组 62例， A组给予瑞舒伐他汀治疗， B组给予阿托伐他汀治疗，观察不稳定性心绞痛临床治疗效果，并分别于治疗前、治疗后检测两组患者的血脂水平。结果：治疗前，两组患者血脂水平比较，差异无统计学意义（ P>0.05）；治疗后，两组患者临床治疗总有效率比较，差异无统计学意义（ P>0.05），但 A组患者血脂水平优于 B组，差异有统计学意义（ P<0.05）。结论：他汀类药物治疗老年不稳定性心绞痛患者时，瑞舒伐他汀与阿托伐他汀疗效相当，但瑞舒伐他汀的降血脂效果更为明显，效果优于阿托伐他汀。
【关键词】 瑞舒伐他汀； 阿托伐他汀； 老年不稳定性心绞痛； 疗效
Abstract: Objective: To compare the effect of rosuvastatin and atorvastatin in the treatment of unstable angina in the elderly. Methods: 124 cases of elderly patients with unstable angina pectoris in our hospital from June 2018 to June 2019 were selected and randomly divided into group A and group B, with 62 cases in each group. Group A was treated with rosuvastatin and group B was treated with atorvastatin The blood lipid level of the two groups was measured before and after treatment. Results: before treatment, there was no significant difference between the two groups (P > 0.05); after treatment, there was no significant difference between the two groups (P > 0.05), but the level of blood lipid in group A was better than that in group B (P < 0.05). Conclusion: in the treatment of elderly patients with unstable angina pectoris, rosuvastatin has the same effect as atorvastatin, but the effect of rosuvastatin is more obvious than that of atorvastatin.
出版日期
2020年08月11日（中国期刊网平台首次上网日期，不代表论文的发表时间）
